OBESITY - 206 Anuncios

Tuesday 12 May 2026

Cantidad : Min.Order - Precio : 1,00 €

Aceite de argán para la alimentación Historia Los bereberes utilizan este aceite para protegerse de los vientos del desierto, pero también lo consumen en la comida para tratar enfermedades cardiovasculares. En la década de 2000, las investigaciones sobre las propiedades del aceite...

Friday 29 August 2025

MT-1 is white powder or lyophilized powder. It adjunct to diet and exercise,help people with obesity lose weight. Ubicación : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 401120 chongqing, Persona a contactar : Anna Wang, +18 0 99 30...

Friday 29 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 29 August 2025

Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. It is mainly used for the treatment of type 2 diabetes. It can lower blood sugar and control blood sugar levels...

Friday 22 August 2025

Cagrilintide is a novel long-acting acylated glucagon analogue under investigation as a non-selective agonist of the amygdalin receptor (AMYR) and calcitonin G-protein-coupled receptor (CChemicalbookTR).Cagrilintide significantly reduces body weight and decreases food intake.Cagrilintide...

Wednesday 20 August 2025

MOTS-c is a peptide hormone encoded in the mitochondrial genome. It regulates metabolic homeostasis and enhances physical performance. It is a mitochondria-derived peptide (MDP) that promotes biosynthesis of the endogenous AMP analog AICAR and consequently AMP-activated protein kinase (AMPK)...

Wednesday 20 August 2025

MT-2 is white powder or lyophilized powder. It adjunct to diet and exercise,help people with obesity lose weight. Ubicación : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 401120 chongqing, Persona a contactar : Anna Wang, +18 0 99...

Wednesday 20 August 2025

MT-1 is white powder or lyophilized powder. It adjunct to diet and exercise,help people with obesity lose weight. Ubicación : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 401120 chongqing, Persona a contactar : Anna Wang, +18 0 99 30...

Wednesday 20 August 2025

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 20 August 2025

Cagrilintide is an amylin-analog, now being developed in combination with the GLP-1 agonist semaglutide to achieve sustained weight loss in persons with overweight and obesity. It is mainly used for the treatment of type 2 diabetes. It can lower blood sugar and control blood sugar levels...

Thursday 14 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 60mg*10via - Precio : USD 650

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 50mg*10via - Precio : USD 550

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 40mg*10via - Precio : USD 450

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 20mg*10via - Precio : USD 300

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 13 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 12 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 09 August 2025

Cantidad : 15mg*10via - Precio : USD 230

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Saturday 09 August 2025

Cantidad : 10mg*10via - Precio : USD 180

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Friday 08 August 2025

MOTS-c is a peptide hormone encoded in the mitochondrial genome. It regulates metabolic homeostasis and enhances physical performance. It is a mitochondria-derived peptide (MDP) that promotes biosynthesis of the endogenous AMP analog AICAR and consequently AMP-activated protein kinase (AMPK)...

Wednesday 06 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Wednesday 06 August 2025

MT-2 is white powder or lyophilized powder. It adjunct to diet and exercise,help people with obesity lose weight. Ubicación : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 401120 chongqing, Persona a contactar : Anna Wang, +18 0 99 30...

Wednesday 06 August 2025

MT-1 is white powder or lyophilized powder. It adjunct to diet and exercise,help people with obesity lose weight. Ubicación : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 401120 chongqing, Persona a contactar : Anna Wang, +18 0 99 30...

Tuesday 05 August 2025

Cantidad : 30mg*10via - Precio : USD 360

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...

Tuesday 05 August 2025

Cantidad : 5mg*10vial - Precio : USD 130

Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). It is an important tool for obesity research. It is an antidiabetic agent against type 2 diabetes (T2D)...